| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.091 | 0.07 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.064 | 0.1 |